To identify additional potential vulnerabilities, we analyzed the Pan-Cancer Atlas DNA methylation dataset for metabolic genes that met three criteria: (1) DNA methylation correlated strongly with gene expression, (2) methylation is variable across tumor types, and (3) the median gene methylation was at least as high as PSAT1 methylation in luminal tumors. This evidence concerns the gene PSAT1 and cancer.